Karyopharm Therapeutics Inc. earnings per share and revenue

KPTI earnings per share for the last quarter are -3.60 USD whereas the estimation was -3.92 USD which accounts for 8.20% surprise. Company revenue for the same period amounts to 30.54 M USD despite the estimated figure of 35.67 M USD. Estimated earnings per share for the next quarter are -4.33 USD, and revenue is expected to reach 34.82 M USD. Also watch annual changes over time to get a bigger picture of KPTI earnings per share and revenue dynamics.